| Prototype | Omicron BA.5.2 | t /χ2 | P |
---|---|---|---|---|
N | 157 | 199 | Â | Â |
SpO2 (%) | 92.50 ± 15.00 | 97.51 ± 1.48 | 4.403 | < 0.001 |
CT |  |  | 142.600 | < 0.001 |
 No pneumonia | 2 (1.3%) | 118 (59.3%) |  |  |
 Ground-glass opacity | 30 (19.1%) | 13 (6.5%) |  |  |
 Local/Bilateral patchy shadowing | 107 (68.2%) | 68 (34.2%) |  |  |
consolidation | 18 (11.5%) | 0 (0.0%) | Â | Â |
White-cell count (×109·L-1) |  |  | 19.080 | < 0.001 |
 ≥ 10 | 19 (12.1%) | 3 (1.5%) |  |  |
 ≥ 4, < 10 | 125 (79.6%) | 167 (83.9%) |  |  |
 < 4 | 13 (8.3%) | 29 (14.6%) |  |  |
Lymphocyte count (×109·L-1) |  |  | 19.980 | < 0.001 |
 ≥ 4 | 2 (1.3%) | 0 (0.0%) |  |  |
 ≥ 0.8, <4 | 97 (61.8%) | 80 (40.2%) |  |  |
 < 0.8 | 58 (36.9%) | 119 (59.8%) |  |  |
Platelet count (×109·L-1) |  |  | 39.740 | < 0.001 |
 ≥ 300 | 4 (2.5%) | 5 (2.5%) |  |  |
 ≥ 100, < 300 | 112 (71.3%) | 187 (94.0%) |  |  |
 < 100 | 41 (26.1%) | 7 (3.5%) |  |  |
Hematocrit (%) | Â | Â | Â | Â |
 (< 40 (male), < 35 (female)) | 98 (62.4%) | 15 (7.5%) | 112.000 | < 0.001 |
CRP (> 8 mg.L-1) | 111 (70.7%) | 73 (36.7%) | 40.670 | < 0.001 |
D-dimer (> 0.55 mg.L-1) | 104 (66.2%) | 8 (4.0%) | 157.600 | < 0.001 |
PT (second) | 11.20 ± 1.68 | 10.46 ± 0.82 | 7.234 | < 0.001 |
INR | 1.00 ± 0.15 | 0.91 ± 0.09 | 4.727 | < 0.001 |
Liver function | Â | Â | Â | Â |
 PA (< 200 mg.L-1) | 128 (81.5%) | 33 (16.6%) | 114.800 | < 0.001 |
 ALB (< 35 g.L-1) | 65 (41.4%) | 1 (0.5%) | 100.100 | < 0.001 |
 TB (> 20.4 umol.L-1) | 53 (33.8%) | 13 (6.5%) | 42.220 | < 0.001 |
 ALT (> 40 U.L-1) | 79 (50.3%) | 22 (11.1%) | 88.610 | < 0.001 |
 AST (> 42 U.L-1) | 59 (37.6%) | 19 (9.5%) | 40.770 | < 0.001 |
 LDH (> 240 U.L-1) | 72 (45.9%) | 3 (1.5%) | 64.250 | < 0.001 |
 GGT (> 50 U.L-1) | 61 (38.9%) | 30 (15.1%) | 10.490 | 0.001 |
 ALP (> 128 U.L-1) | 13 (8.3%) | 3 (1.5%) | 8.635 | 0.003 |
 CHE (> 3700 U.L-1) | 23 (14.6%) | 0 (0.0%) | 17.500 | < 0.001 |